Pemetrexed in combination with cisplatin versus cisplatin monotherapy in patients with recurrent or metastatic head and neck cancer: final results of a randomized, double-blind, placebo-controlled, phase 3 study. [electronic resource]
Producer: 20121126Description: 4694-705 p. digitalISSN:- 1097-0142
- Adult
- Aged
- Antimetabolites, Antineoplastic -- administration & dosage
- Antineoplastic Agents -- therapeutic use
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Carcinoma, Squamous Cell -- drug therapy
- Cisplatin -- therapeutic use
- Double-Blind Method
- Female
- Glutamates -- administration & dosage
- Guanine -- administration & dosage
- Head and Neck Neoplasms -- drug therapy
- Humans
- Male
- Middle Aged
- Neoplasm Recurrence, Local -- drug therapy
- Pemetrexed
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.